 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
|
|
|
|
Phase III
|
|
|
|
NCI-06-C-0088
NCI-P6701, NCT00324727
|
|
| |
Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
|
|
|
|
Phase II, Phase I
|
|
|
|
MCC-13649
LAC-USC-10M-05-2, 6241, NCI-6241, LAC-USC-HS-05-00068, NCT00313508
|
|
| |
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
|
|
|
|
Phase II
|
|
|
|
MCC-15241
MDX-010-16, NCI-6446, 6446, NCT00084656, LAC-USC-10M036
|
|
| |
Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma
|
|
|
|
Phase II
|
|
|
|
PMH-PHL-040
NCI-6916, 6916, NCT00121225
|
|
| |
AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
|
|
|
|
Phase II
|
|
|
|
PMH-PHL-038
7137, NCT00243061
|
|
| |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
|
|
|
Phase II
|
|
|
|
MSKCC-05122
NCT00445965
|
|
| |
VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
|
|
|
|
Phase II
|
|
|
|
CCC-PHII-77
7522, NCT00450255
|
|
| |
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
|
|
|
|
Phase II
|
|
|
|
POHA-0604
06-04, NCT00489944
|
|
| |
Study of Ipilimumab to Treat Melanoma in Patients With Brain Metastases
|
|
|
|
Phase II
|
|
|
|
CA184-042
NCT00623766
|
|
| |
Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF
|
|
|
|
Phase II
|
|
|
|
P2 10140402
R21CA103250, NCT00661622
|
|
